tirzepatide law suit The Outsourcing Facilities Association (OFA) is suing the FDA after the agency removed (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed A class-action lawsuit has been
Description
Visvabharathy V et al
Does Increased Heart Rate Offset the Cardiovascular Benefits

Patients follow strict rules for several months, achieve some success, and eventually return to old habits because the plan was never realistic long term

Not to hear bad news, but to get ahead of anything that might be developing

Tirzepatide pushes two levers at once
